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Abstract. Concerted efforts from national and international partners have scaled up malaria control interventions,
including insecticide-treated nets, indoor residual spraying, diagnostics, prompt andeffective treatment ofmalaria cases,
and intermittent preventive treatment during pregnancy in sub-Saharan Africa (SSA). This scale-up warrants an as-
sessment of its health impact to guide future efforts and investments; however, measuring malaria-speciﬁcmortality and
the overall impact of malaria control interventions remains challenging. In 2007, Roll Back Malaria’s Monitoring and
Evaluation Reference Group proposed a theoretical framework for evaluating the impact of full-coverage malaria control
interventions on morbidity and mortality in high-burden SSA countries. Recently, several evaluations have contributed
new ideas and lessons to strengthen this plausibility design. This paper harnesses that new evaluation experience to
expand the framework, with additional features, such as stratiﬁcation, to examine subgroups most likely to experience
improvement if control programs are working; the use of a national platform framework; and analysis of complete birth
histories from national household surveys. The reﬁned framework has shown that, despite persisting data challenges,
combiningmultiple sources of data, considering potential contributions fromboth fundamental and proximate contextual
factors, and conducting subnational analyses allows identiﬁcation of the plausible contributions of malaria control in-
terventions on malaria morbidity and mortality.
INTRODUCTION
Malaria remains a public heath challenge in sub-Saharan
Africa (SSA) despite concerted efforts from national and in-
ternational partners to scale up effective malaria control in-
terventions, such as insecticide-treated nets (ITNs), indoor
residual spraying (IRS), diagnostics, prompt and effective
treatment of malaria cases, and intermittent preventive
treatment during pregnancy (IPTp). The World Health Orga-
nization (WHO) estimates that between 2001 and 2013, 670
million fewer cases and 4.3 million fewer malaria deaths oc-
curred globally than would have occurred if incidence and
mortality rates had remained unchanged since 2000. Of the
estimated 4.3 million deaths averted between 2001 and
2013, 3.9million, or 92%,were among children under 5 years
of age in SSA.1
Global investments inmalaria control and elimination efforts
exceeded USD $2.7 billion in 2013,1 resulting in a strong de-
sire from funding partners and national malaria control pro-
grams for rigorous evaluations of scaling up malaria control
interventions to quantify the impact on malaria-associated
morbidity and mortality. Several challenges complicate this
task. First, nearly all malaria control interventions are either
implemented as national coverage programs or targeted to
high-transmission risk areas.2,3 In such cases, a contempo-
raneous control group, or counterfactual, is often unavailable,
hindering direct causal inferencebetween exposure tomalaria
control interventions and any observed changes in malaria
health outcomes.4 Second, data on malaria morbidity, mor-
tality, and transmission are often unavailable at the required
scale or are inappropriate for use in analysis. Third, other
factors can affectmalaria health outcomes, such as additional
maternal and child health interventions, socioeconomic con-
ditions, and environmental factors, but they may not be well
documented. Fourth, it is difﬁcult to deﬁne an evaluation’s
baseline, midline, and endline,4,5 so that intervention scale-up
timing and coverage level obtained must be carefully con-
sidered to ensure a complete assessment. Finally, the efﬁcacy
of malaria interventions is already proven, unlike other devel-
opment ﬁelds, the evaluation question is more about program
implementation of proven interventions and the effectiveness.
A rigorous and valid evaluation design must address these
constraints; therefore, in 2007 Roll Back Malaria’s (RBM)
Monitoring and Evaluation Reference Group (MERG) pro-
poseda framework for evaluating full-coveragemalaria control
intervention impactsonmorbidity andmortality in high-burden
SSA countries,6 which was the ﬁrst attempt to propose an
evaluation method that ﬁts malaria-control intervention. That
framework, however, was theoretical andnot yet implemented
to uncover potential challenges.
Because standard academic deﬁnitions of evaluation at-
tribute change in impact measures directly to program inter-
ventions, the framework is not, in the strictest sense, an
impact evaluation. It is more about plausibility design as op-
posed to adequacy and probability design.7 In this article,
impact evaluation refers to the potential contribution of a
package of malaria control interventions, which could be
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national malaria programs, to change malaria morbidity and
mortality (Table 1, deﬁnition of key terms).
This article expands the RBM/MERG framework and
highlights some of the challenges in applying this theoretical
framework. In addition, we take the RBM/MERG framework
further by including secondary analyses to more rigorously
examine causal inference. These analyses include stratiﬁ-
cation, use of a national-platform analytic framework, and
analysis of birth history data from national household sur-
veys to assess child survival. Our framework takes into ac-
count new program data from intervention scale-ups since
2007 and new evaluation experience.8,9 This updated
framework may be useful to stakeholders that are re-
sponsible for implementing and evaluating malaria in-
tervention impacts, such as ministries of health, national
malaria control programs, and development partners that
support malaria control efforts.
MATERIALS AND METHODS
Evaluation objectives. The main objectives of an malaria
control intervention impact evaluations are to 1) measure the
degree of implementation success and outcomes compared
with targets set in the national strategic plan, 2) assess trends
inmalaria-relatedmorbidity and all-cause under-ﬁvemortality
as a complementarymalaria impact indicator, and 3) assess
the plausible attribution of the malaria control intervention
scale-up on malaria-related morbidity and all-cause under-ﬁve
mortality, and also account for contextual factors, such as de-
terminants of malaria transmission and child survival.
Following are the speciﬁc evaluation questions:
c Was the scale-up sufﬁcient enough to affect national-
level malaria-speciﬁc morbidity and all-cause under-ﬁve
mortality?
c Was sustained coverage of malaria control intervention
achieved? Was the coverage equitable across socioeco-
nomic groups?
c Was the increase in coverage of interventions associated
with impact on national all-cause under-ﬁve mortality?
c Was impact highest among those risk groups with the
greatest potential to beneﬁt from exposure to the interven-
tions? And was the impact equitable across socioeconomic
groups?
c Can other plausible explanations of the observed change in
national all-cause under-ﬁve mortality be excluded?
Evaluation design. An experimental study design is as-
sumed to be the gold standard for assessing efﬁcacy of new
interventions.5 Using such a design to evaluate a package
of malaria control interventions is challenging for several rea-
sons, the foremost being a lack of randomization to designate
an intervention group and a control group, or a counterfactual.
Wheremalaria control interventions are scaled up or intensiﬁed
staggered over time, it may be possible to use a step-wedge
quasi-experimental evaluation design.7,10,11 However, the
step-wedge design is subject to variations among wedges
TABLE 1
Deﬁnition of key terms used in this paper
Terms Deﬁnition
All-cause child mortality rate Probability of dying from any cause between the ﬁrst and ﬁfth birthday per 1,000
children who survived to age 12 months17
Civil registration and vital statistics A system for recording vital events in a population, including births and deaths, with
medical certiﬁcationof thecauseofdeathaccording to the rules andproceduresof
the International Classiﬁcation of Diseases
Conﬁrmed malaria case Suspected malaria case in which malaria parasites have been demonstrated in a
patient’s blood by microscopy or a rapid diagnostic test32
Contextual factors Non-malaria programs and other factors, such as rainfall, socioeconomic status,
urbanization, and policy changes, that could confound the association between
scale-up of the intervention and its potential health impact or modify the effect of
the intervention, and affect the conclusion
Impact evaluation Within the context of this paper, impact evaluation refers to thepotential contribution
of a package of malaria control interventions, which could be considered the
national malaria program, to a given outcome
Malaria parasitemia Presence of malaria parasites in the blood or number of parasites per volume of
blood
Malaria parasite prevalence Proportion of children ages 6–59 months with malaria parasite infection17
Malaria transmission Spreadofmalaria bycompletionofa full transmissioncycle (man→mosquito→human)
Malaria transmission intensity (force of infection) Measuredas entomological inoculation rate (EIR): the numberof infectiousmosquito
bites a person is exposed to in a certain time period, typically a year
Malaria-speciﬁc mortality Deaths in which malaria was the underlying cause. The World Health Organization
(1993) deﬁnes it as “the disease or injury which initiated the train of morbid events
leading directly to death”
Plausibility argument An assumption that mortality reductions can be attributed to programs if
improvements are found along the causal pathway between intervention scale-up
and mortality trends7
Population-level malaria morbidity indicators Indicators on malaria morbidity collected through population-based surveys;
examples are malaria parasite prevalence and anemia
Under-ﬁve mortality Probability of dying before the ﬁfth birthday per 1,000 live births
Verbal autopsy Amethod for determining cause of death. A knowledgeable person in the household
where a deceasedperson lived is askedabout signs and symptomsof the terminal
illness, usually 1–6 months after the death.18,22,28 To attribute causes of deaths,
interviews are analyzed by an algorithm or clinicians who decide on causes by
majority vote6
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regarding geographical settings, population, or trans-
mission patterns. The design is also subject to contami-
nation amongwedges, such as the higher burden areasmay
receive interventions ﬁrst, compared with those with lower
burden, and randomizing between the two settings poses
signiﬁcant ethical challenges. Also, limited subnational-
level longitudinal, population-based data on the coverage
of malaria control interventions and health outcomes pre-
cludes evaluation designs, such as a national platform ap-
proach, to assess a dose-response relationship between
coverage and outcomes.11
To address these constraints, a prepost reﬂexive control
study design, also known as the ecological or plausibility
study design, for evaluating the effectiveness of national-
coverage malaria control interventions has been pro-
posed.6,7,11 The plausibility study design contends that if the
interventions have already proven efﬁcacious on malaria out-
comes, then it is plausible that their scale-up could have
contributed to or driven the observed reductions in malaria
burden, unlessother contextual factors andnonmalaria related
interventions are unlikely to explain all of these reductions in
burden. For example, randomized controlled trials have
established protective efﬁcacy of ITN use on the incidence of
malaria illness and all-cause under-ﬁve mortality;12–14 there-
fore, increasing coverage of ITNs use should reduce malaria
morbidity andmortality over a time period consistent with the
impacts established in the trials. The plausibility design is
strengthened if malaria burden baseline levels can be
established before intervention scale-up, with the counter-
factual being that pre-scale-up malaria trends would have
continued in the absence of the interventions. Thus, over
time, the intervention group serves as its own comparison
group (Figure 1).
The strongest plausibility assessment can be made when
there is evidence of a statistically signiﬁcant increase in in-
tervention coverage and use that is substantial enough to
achieve a realistically proportional reduction inmalaria-related
morbidity and all-cause under-ﬁve mortality within the time
frame expected (Table 2). The relationships between in-
creasing coverage and use and reducing morbidity and mor-
tality; however, are not linear. The plausibility assessment
must also document contextual factors, both health-related
and not, that may affect changes in malaria-related morbidity
and child mortality.
This plausibility assessment assumes evaluators can 1)
reliably measure changes in malaria intervention coverage,
malaria health outcomes, and contextual factors over time; 2)
determine that increases in malaria intervention coverage
adequately preceded changes in malaria health outcomes;
and 3) record whether health impact was highest among
speciﬁc risk groups with the greatest potential to beneﬁt from
exposure to the interventions. The plausibility design should
take into consideration all of the Bradford Hill criteria for
causality, as outlined in Table 3.
FIGURE 1. Plausibility study design framework for assessing malaria control intervention impact on malaria morbidity and all-cause child
mortality. ANC=antenatal care; EIR=entomological inoculation rate; EPI = extendedprogram for immunization; ITN= insecticide-treatednet; IRS=
indoor residual spraying; IPTp= intermittent preventive treatment;GDP=gross domestic product;MCM=malaria casemanagement; Vit = vitamin;
PMTCT = prevention of mother to child transmission. This ﬁgure appears in color at www.ajtmh.org.
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Evaluation timing. Strategically timing an impact evalua-
tion is important in achieving the most effective, informative
results. Stakeholders should be enlisted to develop criteria to
deﬁne the evaluation baseline, midline, and end line, based on
when malaria control intervention implementation occurred
and the availability of data points.6 When possible, baseline
outcome measures should be established well before malaria
control intervention scale-up because under-ﬁve mortality
estimates from household surveys reﬂect the situation an
average of 2.5 years preceding the survey. Figure 2 illustrates
a sample evaluation timeframe, including intervention mile-
stones and timing of data sources.
There is no simple, direct way to determine when an impact
evaluation becomes appropriate—the exact time point after
malaria control intervention scale-up begins or the level of
intervention coverage. If the scale-up is still in the early stages,
coverage levels may still be too low, and an impact evaluation
may not be recommended; however, it is difﬁcult to state
a threshold for when national-level impact is likely to be-
comemeasurable. Conducting an evaluation takes substantial
planningand inputs, as illustrated in theprocessofRBM impact
evaluations led by the President’s Malaria Initiative (PMI).15 A
program performance review that assesses program imple-
mentation success may be suitable when impact evaluations
are not.16
Evaluation indicators. Changes in coverage of malaria
control interventions. MERG issued a set of primary
population-level indicators to measure changes in coverage
of key malaria control interventions.17 These indicators
measure how well malaria control interventions are being
TABLE 2
Plausibility study design strengths, limitations, and assumptions
Strengths Limitations Key assumptions
Intervention group serves as its own
control over time
No true counterfactual, so cause and
effect cannot be conclusively inferred
Program is preexisting or full (above
threshold) coverage
No need to exclude any population or
group from the intervention/program,
so can be applied to programs with
nation-wide coverage
Multiple sources of data, analyses, and
triangulations needed to establish
plausible impact
Pretest (baseline) data for the relevant
indicators can serve as counterfactual
scenario
Differential selection bias and attrition risk
to cause bias and dilution of impact
No other plausible explanations for
observed outcomes or any likely
confounder effects can be adjusted for
Can adapt to use existing data collected
for other purposes (DHS, MICS)
Data might not be as speciﬁc as required All-cause under-ﬁve mortality is a
sensitive, speciﬁc, and time-sensitive
proxy for changes in malaria-speciﬁc
mortality in highly endemic countries
TABLE 3
Bradford Hill causality criteria, as applied to plausibility assessment
Criterion Description Assumptions
Strength of association Strong associations are more likely to
have causal components than weaker
associations.
Associations can be measured
Consistency Observing similar evaluation results
across evaluation methods, over time,
and across countries from meta-
analyses increases the likelihood of
causal relationships.
Results have been measure consistently
over time and space
Speciﬁcity Observing an association speciﬁc to
outcomes of interest among speciﬁc
groups increases the argument for
causal effect.
Malaria interventions are highly likely to
reduce all-cause under-ﬁve mortality,
particularly among vulnerable groups
Temporality Changes in program must precede
changes in disease or coverage
outcomes.
Scale-up of interventions has been
measured
Gradient Changes in disease or coverage
outcomes increase the same amount
for increases to program exposure or
intensity.
Coverage has been measured in different
geographic areas
Plausibility Biological plausibility links exposure to
intervention with health outcome.
Malaria contributes to all-cause child
mortality
Coherence Causal inference is possible only if the
literature or substantive knowledge
supports this conclusion
There are documented studies showing
that malaria interventions affect
mortality
Experiment Causation is a valid conclusion if
researchers have seen observed
associations in prior experimental
studies.
There are documented studies showing
that malaria interventions affect
mortality
Analogy For similar programs operating, similar
results can be expected to bolster the
causal inference concluded.
Program context has been similar in the
past
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implemented to meet coverage targets deﬁned in national
malaria control strategies.3 Key indicators include ITN own-
ership and use, households protected by IRS, pregnant
women receiving IPTp, and children receiving effective treat-
ment of malaria (Table 4).
Primary data sources for population-level coverage include
national household surveys, such as the Demographic and
Health Surveys (DHS), Malaria Indicator Surveys (MIS), and
Multiple Indicator Cluster Surveys (MICS). These surveys
typically are conducted every 3–5 years and provide national
FIGURE 2. Example evaluation timeframe, fromEvaluationof the Impact ofMalariaControl InterventionsonAll-CauseMortality inChildrenUnder-
Five in Uganda. Source: Unpublished report). DHS = Demographic and Health Surveys; MIS = Malaria Indicator Survey; ACT = artemisinin-based
combination therapies; LLIN = long-lasting insecticidal nets; IPTp = intermittent preventive treatment of pregnant women.
TABLE 4
Key primary outcome indicators used to assess malaria control intervention scale-up
Indicator Purpose/rationale of indicator
Vector control
Proportion of households with at least one ITN Measures household ITN ownership
Proportion of households with at least one ITN for
every two people
Measures the proportion of households with sufﬁcient ITNs to cover all
individuals who spent the previous night in surveyed households,
assuming an average of two people sharing each ITN
Proportion of population with access to an ITN in
their household
Measures the proportion of the population that could have slept under an
ITN, assuming each ITN is used by two people
Proportion of the population that slept under an ITN
the previous night
Measures the level of ITN use among all individuals who spent the
previous night in surveyed households, regardless of whether those
individuals had access to an ITN in their household
Proportion of children under 5 years old who slept
under an ITN the previous night
Measures the level of ITN use of children under 5 years old.
Proportion of pregnant women who slept under an
ITN the previous night
Measures the level of ITN use among pregnant women
Proportion of existing ITNs used the previous night Measures the use of existing ITNs. In certain instances, calculating the
proportion of existing ITNs used the previous night will be useful for
assessing the utilization of existing ITNs and determining the
magnitude of nonuse of ITNs at the time of the survey
Households coveredby vector control: proportion of
households with at least one ITN and/or sprayed
by IRS in the last 12 months
Measures the proportion of household protected by an ITN or IRS
Universal coverage of vector control: proportion of
households with at least one ITN for every two
peopleor sprayedby IRSwithin the last 12months
Measures progress towards achievement of universal coverage of
malaria prevention through the two main vector control activities
Intermittent preventive treatment during pregnancy
(IPTp)
Proportion of women who received three or more
doses of IPTp for malaria during antenatal care
visits during their last pregnancy
Measures national level coverage of use of IPTp to preventmalaria during
pregnancy among women who gave birth in the last two years.
Case management
Proportion of children under 5 years old with fever in
the last 2 weeks who had a ﬁnger or heel stick
Measures national-level coverage of parasitological diagnosis among
children under 5 years of age
Proportion of children under 5 years old with fever in
the last 2weeks forwhomadviceor treatmentwas
sought from a formal health-care provider
Measures national-level coverage of health seeking behavior for malaria
from the formal health care providers among children under 5 years
Proportion of children under 5 years old with fever in
last 2 weeks who received ﬁrst-line antimalarial
treatment according to national policy
Measures national-level treatment coverage of children under 5 years are
in accordance with national ﬁrst-line malaria treatment policy.
Proportion receiving treatment with recommended
ﬁrst-line antimalarial, among children under 5
years old with fever in the last 2 weeks who
received any antimalarial drugs
Measures what proportion of antimalarial treatment received by children
under 5 years are in accordance with national ﬁrst-line malaria
treatment policy.
Source: Adapted from Roll Back Malaria, 2013, Household Survey Indicators for Malaria Control. ITN = insecticide-treated net; IRS = indoor residual spraying; IPTp = intermittent preventive
treatment of pregnant women.
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and subnational estimates for intervention coverage indica-
tors. Further coverage data may come from health manage-
ment information systems (HMIS), Health and Demographic
Surveillance Systems,18 or special surveys conducted for
speciﬁc projects, such as post-campaign long-lasting in-
secticidal nets coverage surveys. Othermalaria programdata,
such as timing andquantity ofmalaria commodity distribution,
might also help understand intervention coverage. Data from
these sources, with the potential to contribute to measuring
and understanding coverage, should be evaluated for rigor
and incorporated in the analysis when appropriate, consid-
ering scope, sampling, and the data collection method.
Malariamorbidity,mortality, and transmission indicators.
Indicatorsof keymalaria outcomesareused toassesshow the
burden of malaria has changed over time, presumably as a
result of malaria control intervention scale-up. Examples of
these outcomes include malaria morbidity, determined by
prevalence of malaria antigens or parasites; density of para-
sitemia (parasites/μL) or severe anemia (< 8 g/dL) in children
under 5 years of age,19 or all-cause under-ﬁvemortality.When
data are available, an outcome indicator can be determined
from malaria transmission intensity, measured through
malaria infection incidence rates, or force of infection, or the
entomological inoculation rate.20,21
Health Management and Information Systems have the
potential to provide malaria-speciﬁc morbidity and mortality
data, when proper diagnosis and medical certiﬁcation of
cause of death are available. The quality of the data depends
on consistent, appropriate use of diagnostics and inpatient
and outpatient case management. A change in diagnostic
methods over the evaluation period, such as purely clinical
or microscopy or rapid diagnostic test, can affect morbid-
ity trends. In addition, health-care utilization trends and
reporting rates can affect malaria morbidity and mortality
calculations for health facilities. Because health-care utili-
zation rates are low inmost SSAmalaria-endemic countries,
only a potentially time-varying fraction of malaria deaths are
likely to occur at public health facilities. Many malaria-
related deaths occur at homes or at private facilities that do
not link into HMIS.1
Verbal autopsy is so far the only available and accessible
method to measure malaria-speciﬁc mortality at the pop-
ulation level in a context where most deaths occur outside a
formal health facilities. With verbal autopsy, the deceased’s
primary caregivers are interviewed for detailed information
about events leading up to the death to ascertain and assign a
cause.22–25 Existing verbal autopsy tools are not highly sen-
sitive,26 but efforts are underway to increase sensitivity in
detecting cause of death, such as using computer-based al-
gorithms and the simpliﬁed symptom pattern approach.27
Althoughverbal autopsymaynot provide aprecisemeasureof
malaria-speciﬁcmortality, it may give an idea of the ranking of
malaria in a list of causes of death at to population level and
help understand further malaria epidemiology.28 In countries
where such data exist, evaluations should consider exploring
verbal autopsy for use in the plausibility assessment, partic-
ularly as a case studybecause the information inmost cases is
not available at the national level.
Civil registration and vital statistics systems are also po-
tential data sources for measurement of population-level
cause speciﬁc mortality.29 However, in most countries data
are not strong enough to use in impact evaluations at the
national level,30 a circumstance that could change as conﬁr-
mation of malaria diagnosis with parasite density becomes
more routine and medical autopsies are performed.18
In the absence of reliable malaria-speciﬁc mortality data,
and given the large indirect effects that malaria control inter-
ventions have on child health,31 RBM and WHO recommend
using all-cause under-ﬁve mortality as the standard impact
measure in malaria-endemic countries.17,31,32,33 This is com-
monly measured through standardized national household
surveys, such as DHS and MICS, in most malaria-endemic
countries.
Contextual factors. Contextual factors that may inﬂuence
outcome or impact indicators should be investigated for their
potential contribution to changes in the outcomes of interest.
Where possible, these contextual factors should be directly
accounted for in the analytic framework used to assess the
association between changes in malaria control intervention
coverage and malaria health outcomes. Contextual factors
can be divided into two groups, 1) distal (e.g., gross domestic
product, housing condition, maternal education, and climate)
and 2) proximal (e.g., nutritional status, childhood vaccination
coverage, vitamin A supplementation, and breastfeeding).
Fluctuation in contextual factors is expected, so evaluators
should only look for anomalies thatmay explain changes in all-
cause under-ﬁve mortality, within the given the timeframe
(Table 5).
Data analysis. The primarymethod to build plausibility is to
assess trends in malaria intervention coverage, malaria health
outcomes, and potential contextual factors. An example is the
ZanzibarNorth Adistrict programevaluation that incorporated
data from multiple sources, including HMIS-derived monthly
incidence cases as the primary outcome, and explanatory
variables, such as the year of program intervention and
monthly rainfall frommeteorological sources, all analyzed in a
negative-binomial regression framework.34 In another exam-
ple from Zanzibar, evaluators used log-linear regression to
assess reductions in malaria cases and deaths between the
preintervention period of 1999–2003 and 2008.35 Evaluators
concluded that signiﬁcant reductions in malaria cases and
malaria-related mortality were made during the period
evaluated.
Another example is the evaluation of the Bioko Island
Malaria Control Project36 in Equatorial Guinea that assessed
4 years of high-coverage scale-up of IRS, ITNs, and improved
case management on the island. Researchers used survival
regression to measure the change in all-cause mortality
among children under 5 years of age. Calendar year was
included as a covariate to test the presence of a declining
trend in child mortality. Household access to electricity was
included as a proxy indicator of household wealth. A sub-
samplewas used to test the association between rainfall in the
previous 12 months and child mortality. Variables of interest
included possession and use of ITNs, IRS coverage, and
pregnant women protected through IPTp. As hypothesized,
results indicated simultaneous drops in the prevalence of
malaria parasite infection, anemia, reported fever, and all-
cause under-ﬁve mortality in children. This evaluation, how-
ever, did not include an in-depth discussion of contextual
factors that could also have inﬂuenced the decline in all-cause
under-ﬁve mortality.
The RBM impact evaluations, led by PMI, took advantage
of a key strategy for data analysis: risk stratiﬁcation. To
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strengthen the plausibility design, analyses of parasite
prevalence, anemia prevalence, and mortality were strati-
ﬁed by age group, place of residence, andmalaria risk zone,
where data were available.8 The stratiﬁcation helped iden-
tify areas and subpopulations with the greatest potential to
beneﬁt from interventions and assesswhether these groups
experienced the highest reductions in morbidity or mortal-
ity during the evaluation. If reduction in anemia is associ-
ated with malaria decline, we would expect to see a higher
baseline and greater reduction in severe anemia prevalence
in areas with relatively higher malaria risk, considering that
other factors remain constant.37 Furthermore, if amajor part
of the decline in mortality among children under ﬁve was
malaria related, we would expect a greater mortality decline
among children under ﬁve living in areas of greater malaria
risk, compared with areas of lower malaria risk, if other
factors remain constant.37,38 In a similar way, we would
expect a greater decline in mortality among the age group
most likely to experiencemalaria-related death (6–24months),
compared with other childhood age groups, if malaria control
interventions were the main mortality reduction driver.39,40
However, the age groups might change with the reduction of
malaria infection. In countrieswhere signiﬁcant reductionhave
been achieved, it might be advisable to explore older age
groups.
The results from such analyses to assess trends in malaria
morbidity and mortality can be strengthened using further
analytic methods tailored to the available data in a speciﬁc
country. Building on previous work using a national-platform
approach, where districts or district-time units formed the unit
of analysis,41–43 an available survey data analysis in Malawi
used a Poisson model at the district level to examine the
association between ITN coverage and all-cause child
mortality.12 In Uganda and Senegal, evaluators conducted a
regression survival analysis to examine differences in child
survival before and after the scale-up began. Separately, the
analysis examined trends in variables, such as mother’s ed-
ucation, DPT3 coverage, socioeconomic growth, access to
health care, and temperature and rainfall anomalies. These
types of analyses can be undertaken, depending on data
availability and usefulness to the objectives of the evaluation
itself.
Data may also be pooled across countries to provide
evidence ofmalaria control intervention effects at the global
level (Figure 3).19,43 After evaluations have been completed
in several countries and comparable datasets are available,
this kind of meta-analysis could provide more insight into
malaria program effectiveness, especially where in-country
analyses lack sufﬁcient statistical power to detect program
effects.
DISCUSSION
A consistent, accurate method is needed to evaluate the
impact of the remarkable scale-up of malaria control in-
terventions in SSA. Clear methods have yet to be identiﬁed to
directly measure the impact of this scale-up, but this paper
proposes an enhanced plausibility design.
The ability to attribute impact to interventions depends on
the type of design. The gold standard to attribute causality is
TABLE 5
Examples of contextual factors that should be examined
Category Examples Data sources Justiﬁcation
Child survival
interventions
Expanded program on
immunization coverage,
such as measles and DPT3,
WHO, UNICEF annual
estimates of national
immunization coverage
Observed reductions in child morbidity
and mortality may actually be result of
increased coverage of these programs
rather than malaria control
interventions.
micronutrient supplementation
coverage, including vitamin
A, iron, and zinc
UNICEF vitamin A coverage
database
DHS, MICS, MIS
Climatic and
environmental
factors
Total precipitation National meteorological
agency
These factors affect mosquito breeding
and malaria transmission and may
cause observed changes in outcomes
over time or geography, rather than the
interventions themselves.
Number of days with rain Columbia University
Earth Institute climate
database
Land cover and vegetation National Oceanographic and
Atmospheric Administration
Air temperature
Extreme weather events, such
as ﬂoods
Health systems
factors
Per capita expenditure on
health
WHO/WHOSIS Health systems can affect comparisons
across time or geography by
inﬂuencing access to interventions.
These factors modify the impact of
malaria control interventions.
Government expenditure on
health as percentage of total
government expenditure
The World Bank development
indicator database
Availability of essential drugs
Political situation and stability
Socioeconomic
factors
Household assets and income DHS, MICS If different socioeconomic groups access
malaria control interventionsdifferently,
these factors may serve as effect
modiﬁer inﬂuence outcomes.
Parental education The World Bank development
indicator database
Conﬂict or emergency settings
GDP per capita, Gini per capita
Population living below poverty
line
DPT3 = diphtheria, pertussis, tetanus vaccine, 3 doses;WHO=World Health Organization; UNICEF =United Nations Children’s Fund; DHS =Demographic and Health Surveys; MICS =Multiple
Indicator Cluster Surveys; MIS = Malaria Indicator Survey; GDP = gross domestic product.
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an experimental design because of the random assignment of
units to intervention and control groups; however, this design
is challenging for malaria control programs because in-
tervention areas are based on nonrandom considerations and
often are implemented at a national scale. Malaria control
programs fall under the category of “complex intervention
research,”4 with multiple interventions occurring simulta-
neously and interacting. In addition, interventions target vari-
ous groups and sometimes require beneﬁciaries to adapt a
number of behaviors to achieve the intended impact.
The impact evaluation design ofmalaria control intervention
scale-up falls in the area of developing literature oncomplex or
FIGURE 3. Three analytical plans for validating results from primary analysis.
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system-level interventions and plausibility evaluations.4,44
This literature suggests that, in addition tomeasuring changes
in key indicators before andafter an intervention, anevaluation
should include four considerations: 1) a theoretical un-
derstanding of how the intervention causes change through
an impact model; 2) allowance for variability in outcomes,
depending on population characteristics, through the esti-
mation of separate outcomes for different strata; 3) an as-
sessment of the implementation process to determine if any
lack of impact reﬂects implementation failure or genuine in-
effectiveness, which can guide and improve program man-
agement; and 4) a thorough documentation of context to
inform assessments about causality and help generalize re-
sults to other contexts.
The improved plausibility design proposed here builds on
these principles. The design is advantageous in certain set-
tings because it obviates the need for a control group, and it
can assess the impact of national coverage programs. The
success of this design, however, requires comprehensive and
consistently high-quality data, as well as rigorous analytical
techniques.Data frommultiple sources in eachcountry should
be used to compensate for the shortcoming of any one
method of data collection. For example, HMIS often un-
derestimate the total deaths attributed to malaria because
most malaria-related deaths in SSA occur outside of public
health facilities; however, these data can be combined with
conﬁrmed-case reporting to more rigorously assess malaria
control intervention impact.40 Potential confounders should
always be thoroughly investigated in trend analyses and other
statistical models to evaluate the role of these factors on the
health outcomes of interest.
Although the expanded evaluation framework provides a
good basis for evaluating malaria control intervention impact,
it does have some limitations. It is still unclear when or at what
threshold of intervention coverage an impact evaluation
becomes appropriate. The plausibility study design assumes
that scale-up and its impact, along with contextual factors,
can all bemeasured reliably at national and subnational levels;
however, signiﬁcantgapsstill exist indata acquisition systems
in most malaria-endemic countries. The proposed framework
relies exclusively on secondary data and its application de-
pends on the quality of the data. Therefore, additional efforts
need to be put into strict data collection at the national and
subnational levels.
Moreover, baseline data preceding the scale-up of
malaria control interventions do not exist for many coun-
tries, making it difﬁcult to measure change over time.
Countries should continue to invest in strengthening routine
health information system to ensure that periodic house-
hold surveys are complemented by robust longitudinal
data from health facilities where malaria is diagnosed and
treated. This is particularly important in changing malaria
epidemiological context with countries moving from control
to pre-elimination phase. As a starting point, a compre-
hensive mapping and cataloguing of routine health in-
formation systems data elements, data quality and data
gaps will be helpful and serve as a baseline for improvement
of the systems. Although similar mapping and catalogue
exist for household surveys it is lacking for routine health
information systems. Furthermore, baseline coverage lev-
els will continue to shift as ongoing scale-up and mainte-
nance of interventions affect malaria transmission and
environmental changes alter malaria intensity. This new
context will require changes in evaluation approaches and
more reliable, ﬂexible, timely, and representative systems
for measuring changes in malaria control interventions and
health outcomes.
It is also difﬁcult to develop an accurate counterfactual
scenario that captures a prescale-up level of intervention
coverage and program intensity. If malaria was already in
decline before scale-up, then continuation of prescale-up
trends is aconservativeor pessimistic counterfactual because
this scenario must also assume that baseline coverage in-
creases are also continuing. The program’s contribution is
then only the recent acceleration of coverage increases,
without accounting for the past and current scale-up in cov-
erage.On theother hand, ifmalaria hadbeenon the rise before
scale-up, assuming a continuation of that rise as counter-
factual results in an optimistic estimation of impact. Malaria is
an epidemic disease, and often a rise is followed by a decline,
even without program effort. In addition, urbanization and
socioeconomic development may be leading to declining
secular trends in most countries.
The relationship between malaria coverage and impact has
a time lag, and the dynamics of how burden trends respond to
coverage trends is highly nonlinear. Malaria interventionsmay
reach their full impact several years after coverage scale-up;
however, that impact may include a partial rebound: as inter-
ventions reduce cases, people build up less acquired immu-
nity, which can result in older age groups having a ﬁnal new
stabilized burden level that may not be as low as previous
burden levels (e.g., the level 2 years after reaching maximum
intervention coverage).
Despite all these challenges, the plausibility approach pro-
posed in this paper provides a good avenue to document
evidence of malaria control achievements in endemic coun-
tries. However, as data become more available and in-
formation systems are strengthened, further improvement to
this approach will be needed.
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